NanoSphere Health Sciences (CSE:NSHS), parent company of cannabis brand Evolve Formulas, has joined forces with Vertical™, the largest fully integrated company in the legal medical cannabis industry, to launch Evolve’s growing product line in Arizona and California this summer.
NanoSphere Health’s Evolve Formulas brand, which currently has products in over 120 dispensaries in Colorado and initially announced its California expansion earlier this year, operates through licensing IP. The new partnership with Vertical™ will provide planning, permitting, development and operation of cultivation, extraction, manufacturing, distribution and retail facilities in both Arizona and California, to officially offer Evolve products in these crucial markets. As the largest integrated company in the medical cannabis industry, Vertical™ utilizes a 1.2 million square feet grow facility, which they use to supply over 220 retail outlet stores including the production of approximately 250,000 grams of oil per month.
The cannabis product line, Evolve Formulas, consists of two variations of Transdermal NanoSerum™ pens, one THC-dominant and one CBD-dominant in formula. This summer, the company plans to launch an intranasal product and later this year will be introducing an intraoral product. All applications will utilize the NanoSphere Delivery System™, which nano-encapsulates cannabinoid molecules in lipid membranes for transportation through the skin and mucosa in the nose and mouth into the bloodstream within minutes. The result is high bioavailability, minimal wait-time, precision-metered dosing and elimination of adverse side effects. This patented technology is the first and only advanced cannabinoid delivery system and can only be found in NanoSphere Health products.
“This partnership with Vertical™ represents an ongoing phase of growth for Evolve Formulas,” said Robert Sutton, Chairman and CEO of NanoSphere Health Sciences. “Expanding into both Arizona and California this summer allows us to bring our advanced, cutting-edge technology to new consumers and patients in the world’s largest legal cannabis market. This partnership is another important step in bringing our patented technology to all legal states and Canadaover the next 18-24 months.”
J. Smoke Wallin, President of Vertical Companies, running distribution, sales and marketing, added, “Our team at Vertical is rapidly building out the industry leading sales and distribution platform in multiple markets. The building blocks for this are a world class team and the best brand portfolio in the business. We couldn’t be more excited to bring the cutting edge NanoSphere technology embedded in the Evolve brand to the licensed retailers and medical dispensaries throughout AZ and CA.”
For more information or to schedule an interview, please contact Emily Kielthy at firstname.lastname@example.org or 702-957-6203.
On behalf of the Board
Robert Sutton, Chairman and CEO
Victor Goncalves, Executive Vice President
NanoSphere’s Commitment to Licensing IP
NanoSphere launched its IP licensing program in 2015 and is entertaining several licensing opportunities via a rigorous evaluation process. For more information about NanoSphere’s licensing program, please visit: https://www.nanospherehealth.com/licensing/
NanoSphere Health Sciences LLC, is a biotechnology firm specializing in the creation of the patented NanoSphere Delivery System™, a revolutionary platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond. NanoSphere Delivery System™ represents one of the most important developments for advancing the non-invasive and user-friendly delivery of biological agents in over 25 years. For more information on NanoSphere, please visit http://www.nanospherehealth.com.
About Evolve Formulas
Evolve Formulas is the provider of the world’s first and only scientifically proven nanoparticle delivery system in cannabis. Evolve’s pioneering product, Transdermal NanoSerum™, is a fast-acting, ultra-strength transdermal formula infused with nano-encapsulated cannabis and cannabis extracts. NanoSerum™ immediately penetrates the skin to deliver direct-focused results and intelligently carries a full spectrum of cannabinoids and phytochemicals to receptors throughout the body for systemic healing. Evolve Formula products leverage NanoSphere Health Sciences™ patented NanoSphere Delivery System™. The NanoSphere Delivery System™ is a revolutionary platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond. For more information on Evolve Formulas, visit https://www.evolveformulas.com/. Follow us on Facebook, Instagram and Twitter.
Vertical is one of the first and largest vertically integrated companies in the legal medical cannabis industry. We have operations in CA and AZ, combined with strategic partnerships in CO, MI, OR, and other markets which position us well to take advantage of the legalization and normalization of cannabis globally. Vertical is led by an executive team of entrepreneurs and business leaders from the alcohol beverage, agriculture, CPG, distribution, entertainment, food, healthcare and medical industries. Vertical’s operations include planning, permitting, development and operation of cultivation, extraction, manufacturing, distribution and brands. We have world class capabilities in product development, co-packing, branding, marketing, distribution, education, and legal compliance. Vertical does Everything Pertaining to Green.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Forward Looking Statement Caution
This news release includes forward looking statements that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward looking statements, including without limitation any statements concerning the Company’s intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without limitation those relating to the Company’s future operations and business prospects, are based on assumptions none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward looking statements. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward looking statements. Any forward looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward looking statements, whether as a result of new information, future events or otherwise.